Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2015

View Archived Issues

Bristol-Myers Squibb presents CETP inhibitor

Merck & Co. reports development of potent gamma-secretase inhibitors

Ono Pharmaceutical reveals new S1P2 antagonists

New role for S100A4 as a biomarker of metastasis in signet-ring cell carcinoma

Merck & Co. patents HIV integrase inhibitors

Vernalis reports development of PDK inhibitors

Tetra Discovery Partners discloses PDE4 inhibitors

Triolimus fixed-dose combination receives FDA orphan drug designation for angiosarcoma

Calitor Sciences and Sunshine Lake Pharma develop PI3Kdelta inhibitors

CRISPR Therapeutics establishes R&D operations in Massachusetts

Mylan proposes to acquire Perrigo

Bristol-Myers Squibb completes acquisition of Flexus Biosciences

Panther Biotechnology to acquire technology assets of Faulk Pharmaceuticals

New Drosophila model of nephrolithiasis presented

AstraZeneca selects first microRNA from Regulus Therapeutics alliance for clinical development

ADXS-HPV to be added to chemotherapy and radiotherapy in phase II/III anal cancer trial

World Parkinson's Day: Mitomycin-treated ESCs show potential

Novel sGC stimulator shows potent antihypertensive effects

FDA accepts lifitegrast NDA for dry eye and grants priority review status

MedImmune's anti-RSV antibody MEDI-8897 receives FDA fast track designation

Santhera's idebenone given FDA fast track designation for DMD

Merus achieves milestone in bispecific antibody collaboration with Ono

Advanced Proteome Therapeutics discloses anticancer activity of immunotherapy combinations

FDA grants fast track designation to cabozantinib for advanced RCC

Agenus acquires Celexion antibody discovery assets

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...